Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise
Shanghai Fosun Pharmaceutical (Group) (HKG:2196) signed a Share Subscription Agreement with IFC and ADB to invest 270 million yuan each in United Health Insurance, according to a Monday filing with the Hong Kong bourse.
The deal will increase Fosun Pharma's stake in the insurer from 14.00% to 20.05%. The capital infusion, totaling 810 million yuan, will support the company's expansion. The transaction does not require the approval of independent shareholders.
Fosun Pharma views this investment as a strategic move to enhance its presence in China's rapidly growing health insurance sector.
The pharmaceuticals shares were up 6% in Hong Kong and 4% in Shanghai in recent trading.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。